Massachusetts Wealth Management’s AbbVie ABBV Stock Holding History

Massachusetts Wealth Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.35M	Sell	9,325 -25	-0.3%	-$5.38K	0.89%	43
2026 Q1	$2.03M	Sell	9,350 -115	-1%	-$25.5K	0.88%	47
2025 Q4	$2.16M	Sell	9,465 -41	-0.4%	-$9.34K	1.01%	42
2025 Q3	$2.2M	Sell	9,506 -150	-2%	-$30.5K	1.09%	37
2025 Q2	$1.79M	Sell	9,656 -175	-2%	-$32.5K	1.01%	41
2025 Q1	$2.06M	Sell	9,831 -135	-1%	-$26.2K	1.41%	31
2024 Q4	$1.77M	Sell	9,966 -50	-0.5%	-$9.19K	1.09%	44
2024 Q3	$1.98M	Sell	10,016 -125	-1%	-$23.3K	1.25%	38
2024 Q2	$1.74M	Sell	10,141 -125	-1%	-$20.7K	1.17%	37
2024 Q1	$1.87M	Sell	10,266 -200	-2%	-$34.5K	1.32%	31
2023 Q4	$1.62M	Sell	10,466 -159	-1%	-$23.2K	1.31%	30
2023 Q3	$1.58M	Sell	10,625 -125	-1%	-$18.4K	1.45%	23
2023 Q2	$1.45M	Sell	10,750 -75	-0.7%	-$11K	1.39%	28
2023 Q1	$1.73M	Sell	10,825 -625	-5%	-$95.6K	1.78%	18
2022 Q4	$1.69M	Buy	+11,450	New	+$1.76M	1.63%	21

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Massachusetts Wealth Management's ABBV Position: Q2 2026 in Review

Massachusetts Wealth Management reduced its AbbVie (ABBV) stake by 0.27% in Q2 2026, selling an estimated $5.38K and leaving 9,325 shares worth $2.35M. The position accounts for 0.89% of the portfolio, ranked #43.

Massachusetts Wealth Management first reported a position in ABBV in Q4 2022 and has held it in 15 quarters since. 4,216 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Massachusetts Wealth Management held 9,325 shares of AbbVie worth $2.35M as of Q2 2026.
Massachusetts Wealth Management sold 25 AbbVie shares in Q2 2026, an estimated $5.38K.
AbbVie made up 0.89% of Massachusetts Wealth Management's portfolio in Q2 2026, its #43 holding.
Massachusetts Wealth Management first reported a position in AbbVie in Q4 2022 and has held it in 15 quarters since.
4,216 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Massachusetts Wealth Management's 13F filing for Q2 2026, filed 3 Aug 2026.